Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.9 (
glucose-6-phosphatase
)
3,081
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
COP1
is a Ring-Finger E3 ubiquitin ligase that is involved in plant development, mammalian cell survival, growth, and metabolism. Here we report that
COP1
, whose expression is enhanced by insulin, regulates FoxO1 protein stability. We found that in Fao hepatoma cells, ectopic expression of
COP1
decreased, whereas knockdown of
COP1
expression increased the level of endogenous FoxO1 protein without impacting other factors such as C/EBPalpha and CREB (cAMP-response element-binding protein). We further showed that
COP1
binds FoxO1, enhances its ubiquitination, and promotes its degradation via the ubiquitin-proteasome pathway. To determine the biological significance of
COP1
-mediated FoxO1 protein degradation, we have examined the impact of
COP1
on FoxO1-mediated gene expression and found that
COP1
suppressed FoxO1 reporter gene as well as FoxO1 target genes such as
glucose-6-phosphatase
and phosphoenolpyruvate carboxykinase, two key targets for FoxO1 in the regulation of gluconeogenesis, with corresponding changes of hepatic glucose production in Fao cells. We suggest that by functioning as a FoxO1 E3 ligase,
COP1
may play a role in the regulation of hepatic glucose metabolism.
...
PMID:COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. 1881 34